Banda Narsaiah
Research Subjects
Banda Narsaiah has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Chityala Ganesh Kumar
Medicinal Chemistry and Pharmacology Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, India
18 shared publications Y. Poornachandra
Medicinal Chemistry and Pharmacology Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India
12 shared publicationsDesireddy Krishna Swaroop
Fluoroorganic division CSIR-Indian Institute of Chemical Technology, Tarnaka Hyderabad- 500007 India
7 shared publicationsG. Santhosh Kumar
Fluoro Organic Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India
7 shared publicationsNagiri Ravi Kumar
Fluoroorganic division CSIR-Indian Institute of Chemical Technology, Tarnaka Hyderabad- 500007 India
7 shared publicationsR. Naresh Kumar
Fluoroorganic Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India
7 shared publications
Latest Publications
- 17 December 2019
- Published by Wiley in ChemistrySelect
- Vol. 4 (47) , 13768-13771
Synthesis of Highly Substituted Fluoro Chromenones in a “One‐Pot Four‐ Component Strategy” Using NFSI as a Fluorinating Reagent
An efficient one pot four component strategy has been developed for the synthesis of highly substituted fluoro chromenone derivatives ( 5 a‐p ) in good yields from β ‐aryl thio acetanilide, aldehydes, cyclic 1,3‐diketones and NFSI ( N ‐Fluorobenzenesulfonimide) in presence of water. The fluoro imino chromenone intermediate 6 is isolated under the inert condition in high yield.
- 17 December 2019
- Published by Wiley in ChemistrySelect
- Vol. 4 (47) , 13768-13771
Synthesis of Highly Substituted Fluoro Chromenones in a “One‐Pot Four‐ Component Strategy” Using NFSI as a Fluorinating Reagent
An efficient one pot four component strategy has been developed for the synthesis of highly substituted fluoro chromenone derivatives ( 5 a‐p ) in good yields from β ‐aryl thio acetanilide, aldehydes, cyclic 1,3‐diketones and NFSI ( N ‐Fluorobenzenesulfonimide) in presence of water. The fluoro imino chromenone intermediate 6 is isolated under the inert condition in high yield.
- 23 May 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (22) , 3654-3657
Synthesis of α‐Fluoroamides with a C–F Quaternary Stereogenic Center by Electrophilic Fluorination: One‐Pot Four‐Component Strategy
An efficient method for the synthesis of α‐fluoroamides having C–F quaternary stereogenic center was achieved by a one‐pot four‐component strategy under mild reaction conditions. A variety of α‐fluoroamides was synthesized by using 1,3‐dicarbonyl, isocyanide, acetylenedicarboxylate and N‐fluorobenzenesulfonimide (NFSI) systems with good to excellent yields up to 93 %. The current protocol proceeds through the unstable 3‐fluoro 4H‐pyran intermediate, which is key for the reaction and further it can be hydrolyzed due to the high electronegativity of the fluorine atom to produce the desired α‐fluoroamides.
- 23 May 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (22) , 3654-3657
Synthesis of α‐Fluoroamides with a C–F Quaternary Stereogenic Center by Electrophilic Fluorination: One‐Pot Four‐Component Strategy
An efficient method for the synthesis of α‐fluoroamides having C–F quaternary stereogenic center was achieved by a one‐pot four‐component strategy under mild reaction conditions. A variety of α‐fluoroamides was synthesized by using 1,3‐dicarbonyl, isocyanide, acetylenedicarboxylate and N‐fluorobenzenesulfonimide (NFSI) systems with good to excellent yields up to 93 %. The current protocol proceeds through the unstable 3‐fluoro 4H‐pyran intermediate, which is key for the reaction and further it can be hydrolyzed due to the high electronegativity of the fluorine atom to produce the desired α‐fluoroamides.
- 21 March 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (13) , 2409-2413
Gem‐Difluorination of Triazole Alkyl Functionalized Amino Pyrazoles by Selectfluor to Access 4,4‐Difluoro‐pyrazol‐3‐ones/Pyrazol‐3‐imines
We have successfully accomplished gem‐difluorination of triazole alkyl functionalized amino pyrazoles in the presence of Selectfluor under dry condition and obtained 4,4‐difluoro pyrazol‐3‐imines derivatives in high yield. However, in the presence of water, 4,4‐difluoro pyrazol‐3‐one derivatives were afforded.
- 21 March 2019
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (13) , 2409-2413
Gem‐Difluorination of Triazole Alkyl Functionalized Amino Pyrazoles by Selectfluor to Access 4,4‐Difluoro‐pyrazol‐3‐ones/Pyrazol‐3‐imines
We have successfully accomplished gem‐difluorination of triazole alkyl functionalized amino pyrazoles in the presence of Selectfluor under dry condition and obtained 4,4‐difluoro pyrazol‐3‐imines derivatives in high yield. However, in the presence of water, 4,4‐difluoro pyrazol‐3‐one derivatives were afforded.
- 3 January 2019
- Published by Wiley in ChemistrySelect
- Vol. 4 (1) , 138-144
Design and Synthesis of Novel Pyrimidine/Hexahydroquinazoline‐Fused Pyrazolo[3,4‐ b ]Pyridine Derivatives, Their Biological Evaluation and Docking Studies #
Multicomponent reaction protocol has been developed for the synthesis of novel pyrimidine fused pyrazolo[3,4‐ b ]pyridine derivatives ( 7 a‐g ) and hexahydroquinazoline fused pyrazolo[3,4‐ b ] pyridine derivatives ( 8 a‐i ) starting from 3‐amino‐5‐carbethoxy‐6‐trifluoromethyl pyrazolo[3,4‐ b ] pyridine 5 . All the synthesized compounds were evaluated for antibacterial as well as antifungal activities and compounds 7 f, 8 a, 8 c and 8 d exhibited promising antibacterial activity. In particular, compound 2,4,6‐trifluoro substituted pyrimidine fused pyrazolo[3,4‐ b ]pyridine ( 7 f ) showed very good antibacterial activity against the panel of both Gram‐positive and ‐negative bacterial strains. Hexahydroquinazoline fused pyrazolo[3,4‐ b ]pyridine derivatives (8 f‐i) also showed promising antifungal activity and broad‐spectrum anti‐biofilm activity against both Gram‐positive and negative bacterial strains. The crystal structure of compound 8 b was solved based on single crystal X‐ray diffraction study. Docking studies were performed to identify the interactions of the compounds 7 f with crtM enzyme of Staphylococcus aureus .
- 3 January 2019
- Published by Wiley in ChemistrySelect
- Vol. 4 (1) , 138-144
Design and Synthesis of Novel Pyrimidine/Hexahydroquinazoline‐Fused Pyrazolo[3,4‐ b ]Pyridine Derivatives, Their Biological Evaluation and Docking Studies #
Multicomponent reaction protocol has been developed for the synthesis of novel pyrimidine fused pyrazolo[3,4‐ b ]pyridine derivatives ( 7 a‐g ) and hexahydroquinazoline fused pyrazolo[3,4‐ b ] pyridine derivatives ( 8 a‐i ) starting from 3‐amino‐5‐carbethoxy‐6‐trifluoromethyl pyrazolo[3,4‐ b ] pyridine 5 . All the synthesized compounds were evaluated for antibacterial as well as antifungal activities and compounds 7 f, 8 a, 8 c and 8 d exhibited promising antibacterial activity. In particular, compound 2,4,6‐trifluoro substituted pyrimidine fused pyrazolo[3,4‐ b ]pyridine ( 7 f ) showed very good antibacterial activity against the panel of both Gram‐positive and ‐negative bacterial strains. Hexahydroquinazoline fused pyrazolo[3,4‐ b ]pyridine derivatives (8 f‐i) also showed promising antifungal activity and broad‐spectrum anti‐biofilm activity against both Gram‐positive and negative bacterial strains. The crystal structure of compound 8 b was solved based on single crystal X‐ray diffraction study. Docking studies were performed to identify the interactions of the compounds 7 f with crtM enzyme of Staphylococcus aureus .
- 17 September 2018
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 55 (11) , 2538-2544
Studies on Synthesis of Novel Pyrido[2,3‐d] pyrimidine Derivatives and Their Anticancer Activity
A series of novel pyrido[2,3‐d]pyrimidine derivatives 7 were prepared starting from 2‐amino nicotinonitrile 3 via Grignard̛s reaction followed by cyclization and nucleophilic substitution. All the products 7 were screened against four human cancer cell lines. Compounds 7b, 7e, 7m, and 7o that showed good activity against all the cell lines have been identified.
- 17 September 2018
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 55 (11) , 2538-2544
Studies on Synthesis of Novel Pyrido[2,3‐d] pyrimidine Derivatives and Their Anticancer Activity
A series of novel pyrido[2,3‐d]pyrimidine derivatives 7 were prepared starting from 2‐amino nicotinonitrile 3 via Grignard̛s reaction followed by cyclization and nucleophilic substitution. All the products 7 were screened against four human cancer cell lines. Compounds 7b, 7e, 7m, and 7o that showed good activity against all the cell lines have been identified.
- 18 July 2018
- Published by Wiley in ChemistrySelect
- Vol. 3 (27) , 7813-7821
Synthesis of Novel Pyrido[2′, 3′:3,4]Pyrazolo[1, 5‐ a ]Quinazoline Derivatives, Their Biological Evaluation and Molecular Modelling Studies
A series of novel ethyl 9‐(trifluoromethyl) pyrido [2′, 3′:3,4]pyrazolo[1, 5‐ a ]quinazoline‐8‐carboxylate 4 , 9‐(trifluoromethyl)pyrido[2′, 3′:3,4]pyrazolo[1, 5‐ a ]quinazoline‐8‐carboxylic acid 5, aryl amide functionalized pyrido[2′, 3′:3,4]pyrazolo [1, 5‐ a ] quinazoline derivatives 6 a‐f , secondary amide functionalized pyrido[2′, 3′:3,4] pyrazolo[1, 5‐ a ]quinazoline derivatives 7 a‐d and primary amide functionalized pyrido[2′, 3′:3,4]pyrazolo[1, 5‐ a ] quinazoline derivatives 8 a‐h were prepared starting from 2(1 H )pyridone 1 . All the compounds were evaluated for antibacterial activity against Gram‐positive and Gram‐negative bacterial strains and the compounds 5 , 6 a , 6 c , 6 f , 7 a , 8 c , 8 f and 8 h exhibited promising antibacterial activity against various bacterial strains. Compound 5 showed high antibacterial (MIC value of 3.9 μg/mL) and broad‐spectrum anti bio‐film activity. Compound 5 and 8 b also showed good antifungal activity against the tested panel of various Candida strains. Molecular docking studies revealed that, the compound 5 and 8 b showed good binding interactions and corroborates with the antifungal results. All the compounds also screened for cytotoxicity and the compounds 7 d , 8 a , 8 b and 8 d exhibited above 90% inhibition against MCF7 (breast) cancer cell line and the compounds 6 d , 7 a , 8 a , 8 b , 8 f and 8 g exhibited above 90% inhibition against SKOV3 (ovarian) cell line, with reference to Doxorubicin (Control) drug in terms of inhibition.
- 18 July 2018
- Published by Wiley in ChemistrySelect
- Vol. 3 (27) , 7813-7821
Synthesis of Novel Pyrido[2′, 3′:3,4]Pyrazolo[1, 5‐ a ]Quinazoline Derivatives, Their Biological Evaluation and Molecular Modelling Studies
A series of novel ethyl 9‐(trifluoromethyl) pyrido [2′, 3′:3,4]pyrazolo[1, 5‐ a ]quinazoline‐8‐carboxylate 4 , 9‐(trifluoromethyl)pyrido[2′, 3′:3,4]pyrazolo[1, 5‐ a ]quinazoline‐8‐carboxylic acid 5, aryl amide functionalized pyrido[2′, 3′:3,4]pyrazolo [1, 5‐ a ] quinazoline derivatives 6 a‐f , secondary amide functionalized pyrido[2′, 3′:3,4] pyrazolo[1, 5‐ a ]quinazoline derivatives 7 a‐d and primary amide functionalized pyrido[2′, 3′:3,4]pyrazolo[1, 5‐ a ] quinazoline derivatives 8 a‐h were prepared starting from 2(1 H )pyridone 1 . All the compounds were evaluated for antibacterial activity against Gram‐positive and Gram‐negative bacterial strains and the compounds 5 , 6 a , 6 c , 6 f , 7 a , 8 c , 8 f and 8 h exhibited promising antibacterial activity against various bacterial strains. Compound 5 showed high antibacterial (MIC value of 3.9 μg/mL) and broad‐spectrum anti bio‐film activity. Compound 5 and 8 b also showed good antifungal activity against the tested panel of various Candida strains. Molecular docking studies revealed that, the compound 5 and 8 b showed good binding interactions and corroborates with the antifungal results. All the compounds also screened for cytotoxicity and the compounds 7 d , 8 a , 8 b and 8 d exhibited above 90% inhibition against MCF7 (breast) cancer cell line and the compounds 6 d , 7 a , 8 a , 8 b , 8 f and 8 g exhibited above 90% inhibition against SKOV3 (ovarian) cell line, with reference to Doxorubicin (Control) drug in terms of inhibition.
- 1 July 2018
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (13) , 2328-2337
Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies
- 1 July 2018
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (13) , 2328-2337
Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies
- 1 May 2018
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (9) , 1670-1675
Studies on synthesis of novel pyrido[2,3-d]pyrimidine derivatives, evaluation of their antimicrobial activity and molecular docking
- 1 May 2018
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (9) , 1670-1675
Studies on synthesis of novel pyrido[2,3-d]pyrimidine derivatives, evaluation of their antimicrobial activity and molecular docking
- 27 February 2018
- Published by Wiley in ChemistrySelect
- Vol. 3 (8) , 2398-2403
Novel 1,2,3‐Triazole‐Functionalized 1,2‐Benzothiazine 1,1‐Dioxide Derivatives: Regioselective Synthesis, Biological Evaluation and Docking Studies
A series of novel 1,2‐benzothiazine‐1,1‐dioxide derivatives (Z)‐3‐hydroxy‐1‐(4‐hydroxy‐2‐methyl‐1,1‐dioxido‐2H‐benzo[e][1, 2]thiazin‐3‐yl)‐3‐phenyl substituted prop‐2‐en‐1‐one ( 6 a‐d ) were synthesized starting from sodium salt of saccharin 1 in series of steps via 3‐acetyl‐2‐methyl‐1,1‐dioxido‐2H‐benzo[e][1, 2]thiazin‐4‐yl substituted benzoates ( 5 a‐d ). Compound 6 e was obtained alternately from 1‐(4‐Hydroxy‐2‐methyl‐1,1‐dioxo‐1,2‐dihydro‐1λ6‐benzo[e][1, 2]thiazin‐3‐yl)‐ethanone ( 4 ). Compounds 6 a‐e were further reacted with aromatic azides to form (4‐hydroxy‐2‐methyl‐1,1‐dioxido‐2H‐benzo[e][1, 2]thiazin‐3‐yl)(1‐substitutedphenyl)‐5‐ substituted pheny or methyl‐1H‐1,2,3‐triazol‐4‐yl)methanone derivatives ( 7 a‐o ) by regioselective cyclization. All the compounds were evaluated for anti‐inflammatory and anti‐cancer activities. Compounds 5 a‐b , 6 a‐b , 7 a , 7 c‐d , 7 i and 7 k‐l which showed significant anti‐inflammatory activity at micro molar concentration have been identified. Also screened for cytotoxic activity against four human cancer cells and one normal cell such as prostate cancer (PC‐3), breast adenocarcinoma (MDA‐MB‐231), liver hepatocellular carcinoma (Hep G2), cervical cancer (HeLa) and normal umbilical vein endothelial cell (HUVEC). Compounds 6 a , 7 g , 7 h and 7 k have been identified as promising candidates. Further, anti‐inflammatory activity is also validated by docking studies and compounds 5 a , 5 b and 7 d found to show good interactions when docked with IL‐1β signaling complex.
- 27 February 2018
- Published by Wiley in ChemistrySelect
- Vol. 3 (8) , 2398-2403
Novel 1,2,3‐Triazole‐Functionalized 1,2‐Benzothiazine 1,1‐Dioxide Derivatives: Regioselective Synthesis, Biological Evaluation and Docking Studies
A series of novel 1,2‐benzothiazine‐1,1‐dioxide derivatives (Z)‐3‐hydroxy‐1‐(4‐hydroxy‐2‐methyl‐1,1‐dioxido‐2H‐benzo[e][1, 2]thiazin‐3‐yl)‐3‐phenyl substituted prop‐2‐en‐1‐one ( 6 a‐d ) were synthesized starting from sodium salt of saccharin 1 in series of steps via 3‐acetyl‐2‐methyl‐1,1‐dioxido‐2H‐benzo[e][1, 2]thiazin‐4‐yl substituted benzoates ( 5 a‐d ). Compound 6 e was obtained alternately from 1‐(4‐Hydroxy‐2‐methyl‐1,1‐dioxo‐1,2‐dihydro‐1λ6‐benzo[e][1, 2]thiazin‐3‐yl)‐ethanone ( 4 ). Compounds 6 a‐e were further reacted with aromatic azides to form (4‐hydroxy‐2‐methyl‐1,1‐dioxido‐2H‐benzo[e][1, 2]thiazin‐3‐yl)(1‐substitutedphenyl)‐5‐ substituted pheny or methyl‐1H‐1,2,3‐triazol‐4‐yl)methanone derivatives ( 7 a‐o ) by regioselective cyclization. All the compounds were evaluated for anti‐inflammatory and anti‐cancer activities. Compounds 5 a‐b , 6 a‐b , 7 a , 7 c‐d , 7 i and 7 k‐l which showed significant anti‐inflammatory activity at micro molar concentration have been identified. Also screened for cytotoxic activity against four human cancer cells and one normal cell such as prostate cancer (PC‐3), breast adenocarcinoma (MDA‐MB‐231), liver hepatocellular carcinoma (Hep G2), cervical cancer (HeLa) and normal umbilical vein endothelial cell (HUVEC). Compounds 6 a , 7 g , 7 h and 7 k have been identified as promising candidates. Further, anti‐inflammatory activity is also validated by docking studies and compounds 5 a , 5 b and 7 d found to show good interactions when docked with IL‐1β signaling complex.